Lobeglitazone Completed Phase 3 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01106131Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
NCT01001611An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus